The Patent Finder

Spera Pharma, Inc.

Also on record
Records under this name other than the patents Spera Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 7 of 7 · Back to Spera Pharma, Inc.

PatentTitleStatus Expires Confidence
US 12,479,798Method for Producing Pyrrolidine Compound
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,981,147Diphosphine Ligand and Transition Metal Complex Using the Same
Term ended
Term ended Sep 20, 2026 · Medium confidence
Term endedTerm ended Sep 20, 2026Medium confidence
US 8,691,718Diphosphine Ligand and Transition Metal Complex Using the Same
Lapsed on the fee record
Ended Apr 8, 2026 · High confidence
Lapsed on the fee recordEnded Apr 8, 2026High confidence
US 7,208,633Process for Preparation of Diphosphine Compounds and Intermediates for the Process
Term ended
Term ended Jan 26, 2024 · High confidence
Term endedTerm ended Jan 26, 2024High confidence
US 7,135,582Transition Metal Complex Having Diphosphine Compound as Ligand
Term ended
Term ended Jan 13, 2024 · High confidence
Term endedTerm ended Jan 13, 2024High confidence
US 7,678,942Process for preparation of diphosphine compounds and intermediates for the process
Term ended
Term ended Dec 5, 2022 · From the USPTO record
Term endedTerm ended Dec 5, 2022From the USPTO record
US 8,053,604Process for preparation of diphosphine compounds and intermediates for the process
Term ended
Ended no later than Dec 5, 2022 · From the USPTO record
Term endedEnded no later than Dec 5, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited